# A Case of Pancreatic Neuroendocrine Tumor Growing Intraductal Extension toward the Main Pancreatic Duct Complicated by Thrombocytopenia: Diagnostic Challenges and Management Strategy

**Authors:** Koichi Soga, Kazuma Sakakibara, Yuki Soma, Manayu Shiina, Mayumi Yamaguchi, Masaru Kuwada, Ryosaku Shirahashi, Ikuhiro Kobori, Shinichi Ban, Masaya Tamano

PMC · DOI: 10.1002/deo2.70241 · 2025-11-03

## TL;DR

A rare case of a pancreatic tumor growing into the main pancreatic duct is described, along with challenges in diagnosis and management due to low platelet count.

## Contribution

This case highlights the diagnostic challenges and management of intraductal pancreatic neuroendocrine tumors in patients with thrombocytopenia.

## Key findings

- A pancreatic neuroendocrine tumor with intraductal extension was confirmed via surgery.
- Serial pancreatic juice aspiration cytology improved diagnostic accuracy over time.
- Tailored strategies are needed for diagnosing pancreatic tumors in patients with hematological fragility.

## Abstract

We present a rare and diagnostically challenging case of a pancreatic neuroendocrine tumor (pNET) with intraductal growth into the main pancreatic duct (MPD), complicated by severe thrombocytopenia due to myelodysplastic syndrome. A 37‐year‐old male presented with thrombocytopenia. Abdominal imaging revealed an 11‐mm hypervascular lesion obstructing the MPD in the pancreatic body. The initial serial pancreatic juice aspiration cytological examination (SPACE) demonstrated Class II cytology. Eight months later, the second SPACE revealed Class V cytology. Pancreaticoduodenectomy confirmed pNET G2 with clear intraductal extension. In the postoperative specimen, a portion of the tumor was exposed within the MPD, suggesting Class V cytology. pNETs with intraductal extension (I‐pNETs) are rare, as pNETs typically exhibit expansive encapsulated growth. SPACE may be a valuable diagnostic alternative for patients with thrombocytopenia, although its accuracy may depend on factors such as capsular integrity and ductal communication. Tailored diagnostic strategies that balance invasiveness and safety are essential for managing pancreatic tumors in patients with hematological fragility. This case highlights the importance of considering I‐pNET in the differential diagnosis of MPD‐occupying lesions.

## Linked entities

- **Diseases:** pancreatic neuroendocrine tumor (MONDO:0019954), myelodysplastic syndrome (MONDO:0018881), thrombocytopenia (MONDO:0002049)

## Full-text entities

- **Diseases:** pNETs (MESH:D018242), myelodysplastic syndrome (MESH:D009190), pancreatic tumors (MESH:D010190), Pancreatic Neuroendocrine Tumor (MESH:D018358), tumor (MESH:D009369), Thrombocytopenia (MESH:D013921), hematological fragility (MESH:D006402)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12582909/full.md

---
Source: https://tomesphere.com/paper/PMC12582909